Diagnostic Accuracy of Procalcitonin, Neutrophil-to-Lymphocyte Ratio, and C-Reactive Protein in Detection of Bacterial Infections and Prediction of Outcome in Nonneutropenic Febrile Patients with Lung Malignancy

Abstract EN

Background.

Procalcitonin (PCT), C-reactive protein (CRP), and neutrophil-to-lymphocyte ratio (NLR) have emerged as important markers of inflammation, and these markers, especially PCT and CRP, have been studied in patients with neutropenia.

This study was designed to evaluate their value in differentiating infectious fever from tumor fever (TF) and to investigate their role in assessing outcomes in nonneutropenic lung cancer patients (NNLCPs).

Methods.

This retrospective clinical study included 588 febrile NNLCPs between January 2019 and December 2019.

The levels of PCT, CRP, and conventional inflammatory markers, including white blood cells (WBC) and neutrophils (NEU), were measured.

NLR was defined as the ratio of the absolute neutrophil count to the absolute lymphocyte count.

Patients’ clinical and bacteriological data were recorded.

Results.

This study included 311 NNLCPs with bacterial infections and 277 with TF.

Inflammatory markers such as PCT, CRP, WBC, and NEU levels and NLR were significantly higher in patients with bacterial infections than in those with TF (p < 0.0001).

However, PCT level was the best predictor of bacterial infections, with an area under the curve (AUC) of 0.874, followed by CRP level (AUC = 0.855) and NLR (AUC = 0.792) (p < 0.0001).

Additionally, PCT level was significantly elevated in patients with bacterial infections with progressive disease after radiotherapy and chemotherapy (p < 0.01).

Conclusions.

The present study demonstrated the superiority of PCT over CRP and NLR in the diagnosis of febrile patients with bacterial infections.

Additionally, PCT can be used to assess the clinical outcomes and cancer progression in NNLCPs.